• Explore /
  • Poster
  • / Multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for second line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for second line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Abstract Poster

Authors

null

Nadja M Meindl-Beinker

Universitätsmedizin Mannheim, Dept. of Medicine II, Mannheim, Germany

Nadja M Meindl-Beinker , Nicolai Hartel , Martin Maenz , Johannes Betge , Matthias Philip Ebert

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Prevention, Diagnosis, and Screening

Clinical Trial Registration Number

NCT03416244

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS174)

DOI

10.1200/JCO.2019.37.4_suppl.TPS174

Abstract #

TPS174

Poster Bd #

N6

Abstract Disclosures

Similar Posters

First Author: Matthias Philip Ebert

First Author: Nicolai Hartel

First Author: Markus H. Moehler

First Author: Praveen Aanur